tetradecanoylphorbol acetate has been researched along with Myotonic Dystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiura, S; Koebis, M; Ohno, S; Suo, S; Zhao, Y | 1 |
| Andre, P; Benoliel, AM; Bongrand, P; Capo, C; Mege, JL; Pouget, J; Serratrice, G | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Myotonic Dystrophy
| Article | Year |
|---|---|
Regulation of the alternative splicing of sarcoplasmic reticulum Ca²⁺-ATPase1 (SERCA1) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway.
Topics: Alternative Splicing; Exons; HEK293 Cells; Humans; Indoles; Myotonic Dystrophy; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-delta; Protein Kinase Inhibitors; RNA Interference; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Tetradecanoylphorbol Acetate | 2012 |
Myotonic dystrophy: defective oxidative burst of polymorphonuclear leukocytes.
Topics: Adult; Humans; Membrane Potentials; Middle Aged; Myotonic Dystrophy; N-Formylmethionine Leucyl-Phenylalanine; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Oxidation-Reduction; Protein Kinase C; Superoxides; Tetradecanoylphorbol Acetate | 1988 |